ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease

PO Katz, KB Dunbar, FH Schnoll-Sussman… - Official journal of the …, 2022 - journals.lww.com
Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …

Aspiration pneumonia

LA Mandell, MS Niederman - New England Journal of Medicine, 2019 - Mass Medical Soc
Aspiration Pneumonia | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter
Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge, lead a …

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional …

DJ Birnkrant, K Bushby, CM Bann, SD Apkon… - The Lancet …, 2018 - thelancet.com
Since the publication of the Duchenne muscular dystrophy (DMD) care considerations in
2010, multidisciplinary care of this severe, progressive neuromuscular disease has evolved …

[HTML][HTML] Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching

SW Lee, EK Ha, AÖ Yeniova, SY Moon, SY Kim… - Gut, 2021 - gut.bmj.com
Objective The adverse effects of proton pump inhibitors (PPIs) have been documented for
pneumonia; however, there is no consensus regarding whether the use of PPIs might be …

Idiopathic pulmonary fibrosis

FJ Martinez, HR Collard, A Pardo, G Raghu… - Nature reviews Disease …, 2017 - nature.com
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by
progressive lung scarring and the histological picture of usual interstitial pneumonia (UIP). It …

The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association

DE Freedberg, LS Kim, YX Yang - Gastroenterology, 2017 - Elsevier
Background & Aims The purpose of this review is to evaluate the risks associated with long-
term use of proton pump inhibitors (PPIs), focusing on long-term use of PPIs for three …

[HTML][HTML] Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options

L Kuna, J Jakab, R Smolic, N Raguz-Lucic… - Journal of clinical …, 2019 - mdpi.com
Peptic ulcer is a chronic disease affecting up to 10% of the world's population. The formation
of peptic ulcers depends on the presence of gastric juice pH and the decrease in mucosal …

Diagnosis and treatment of peptic ulcer disease

RT Kavitt, AM Lipowska, A Anyane-Yeboa… - The American journal of …, 2019 - Elsevier
Peptic ulcer disease continues to be a source of significant morbidity and mortality
worldwide. Approximately two-thirds of patients found to have peptic ulcer disease are …

Advances in the diagnosis and management of gastroesophageal reflux disease

DA Katzka, PJ Kahrilas - Bmj, 2020 - bmj.com
Gastroesophageal reflux disease (GERD) is a multifaceted disorder encompassing a family
of syndromes attributable to, or exacerbated by, gastroesophageal reflux that impart …

Proton pump inhibitor use and the risk of chronic kidney disease

B Lazarus, Y Chen, FP Wilson, Y Sang… - JAMA internal …, 2016 - jamanetwork.com
Importance Proton pump inhibitors (PPIs) are among the most commonly used drugs
worldwide and have been linked to acute interstitial nephritis. Less is known about the …